Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jun;29(6):1116-9.
doi: 10.1093/ndt/gfu098.

Con: renal denervation for all resistant hypertensive patients: the Emperor's new clothes

Alexandre Persu  1 , Yu Jin  2 , Jean-Philippe Lengelé  3 , Lotte Jacobs  2 , Jean Renkin  1 , Jan A Staessen  4
Affiliations
Comment

Con: renal denervation for all resistant hypertensive patients: the Emperor's new clothes

Alexandre Persu et al. Nephrol Dial Transplant. 2014 Jun.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1:
FIGURE 1:
Individual responses of systolic (A, C) and diastolic (B, D) blood pressure on office (A, B) and 24-h ambulatory (C, D) measurement after renal denervation in 109 patients from the ENCOReD network. These results highlight the crucial importance of identification of responder profiles before renal denervation is considered an established treatment of resistant hypertension (adapted from reference [16], with authorization).
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–1281. - PubMed
    1. Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–1909. - PubMed
    1. Symplicity HTN-1 investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911–917. - PubMed
    1. Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet. 2010;376:1878–1880. - PubMed
    1. Persu A, Renkin J, Thijs L, et al. Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension. 2012;60:596–606. - PMC - PubMed